Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Measles elimination: progress and challenges.
Cutts FT, Henao-Restrepo A, Olivé JM. Cutts FT, et al. Vaccine. 1999 Oct 29;17 Suppl 3:S47-52. doi: 10.1016/s0264-410x(99)00309-6. Vaccine. 1999. PMID: 10559534 Review.
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.
Henao-Restrepo AM, Longini IM, Egger M, Dean NE, Edmunds WJ, Camacho A, Carroll MW, Doumbia M, Draguez B, Duraffour S, Enwere G, Grais R, Gunther S, Hossmann S, Kondé MK, Kone S, Kuisma E, Levine MM, Mandal S, Norheim G, Riveros X, Soumah A, Trelle S, Vicari AS, Watson CH, Kéïta S, Kieny MP, Røttingen JA. Henao-Restrepo AM, et al. Lancet. 2015 Aug 29;386(9996):857-66. doi: 10.1016/S0140-6736(15)61117-5. Epub 2015 Aug 3. Lancet. 2015. PMID: 26248676 Clinical Trial.
Ebola vaccination - Authors' reply.
Longini IM, Egger M, Dean NE, Edmunds WJ, Henao-Restrepo AM; study steering group. Longini IM, et al. Among authors: henao restrepo am. Lancet. 2015 Dec 19;386(10012):2480. doi: 10.1016/S0140-6736(15)00951-4. Epub 2015 Dec 18. Lancet. 2015. PMID: 26738716 No abstract available.
Changes in the primary outcome in Ebola vaccine trial--Authors' reply.
Kieny MP, Longini IM, Henao-Restrepo AM, Watson CH, Egger M, Edmunds WJ. Kieny MP, et al. Among authors: henao restrepo am. Lancet. 2016 Apr 9;387(10027):1509-1510. doi: 10.1016/S0140-6736(16)00686-3. Epub 2016 Apr 7. Lancet. 2016. PMID: 27115974 No abstract available.
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).
Henao-Restrepo AM, Camacho A, Longini IM, Watson CH, Edmunds WJ, Egger M, Carroll MW, Dean NE, Diatta I, Doumbia M, Draguez B, Duraffour S, Enwere G, Grais R, Gunther S, Gsell PS, Hossmann S, Watle SV, Kondé MK, Kéïta S, Kone S, Kuisma E, Levine MM, Mandal S, Mauget T, Norheim G, Riveros X, Soumah A, Trelle S, Vicari AS, Røttingen JA, Kieny MP. Henao-Restrepo AM, et al. Lancet. 2017 Feb 4;389(10068):505-518. doi: 10.1016/S0140-6736(16)32621-6. Epub 2016 Dec 23. Lancet. 2017. PMID: 28017403 Free PMC article. Clinical Trial.
Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report.
Gsell PS, Camacho A, Kucharski AJ, Watson CH, Bagayoko A, Nadlaou SD, Dean NE, Diallo A, Diallo A, Honora DA, Doumbia M, Enwere G, Higgs ES, Mauget T, Mory D, Riveros X, Oumar FT, Fallah M, Toure A, Vicari AS, Longini IM, Edmunds WJ, Henao-Restrepo AM, Kieny MP, Kéïta S. Gsell PS, et al. Among authors: henao restrepo am. Lancet Infect Dis. 2017 Dec;17(12):1276-1284. doi: 10.1016/S1473-3099(17)30541-8. Epub 2017 Oct 9. Lancet Infect Dis. 2017. PMID: 29033032 Free PMC article.
Questionable efficacy of the rVSV-ZEBOV Ebola vaccine - Authors' reply.
Longini IM, Røttingen JA, Kieny MP, Edmunds WJ, Henao-Restrepo AM. Longini IM, et al. Among authors: henao restrepo am. Lancet. 2018 Mar 17;391(10125):1021-1022. doi: 10.1016/S0140-6736(18)30559-2. Epub 2018 Mar 15. Lancet. 2018. PMID: 29565012 No abstract available.
An online decision tree for vaccine efficacy trial design during infectious disease epidemics: The InterVax-Tool.
Bellan SE, Eggo RM, Gsell PS, Kucharski AJ, Dean NE, Donohue R, Zook M, Edmunds WJ, Odhiambo F, Longini IM Jr, Brisson M, Mahon BE, Henao-Restrepo AM. Bellan SE, et al. Among authors: henao restrepo am. Vaccine. 2019 Jul 18;37(31):4376-4381. doi: 10.1016/j.vaccine.2019.06.019. Epub 2019 Jun 24. Vaccine. 2019. PMID: 31242963 Free PMC article.
51 results